Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.50
+0.26 (3.59%)
At close: May 16, 2025, 4:00 PM
7.50
0.00 (0.00%)
After-hours: May 16, 2025, 4:20 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $442.61 million as of May 16, 2025. Its market cap has decreased by -63.43% in one year.
Market Cap
442.61M
Enterprise Value
140.62M
1-Year Change
-63.43%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $442.61M, a decrease of -46.64%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 442.61M | -37.59% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |